Clinical Trial

Smart Angioplasty Research Team-Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion With Drug-Coated Balloon

Study acronym: SMART-DCB
Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, multi-center, open-label, randomized controlled, superiority trial. The aim of the study is to compare clinical outcomes between upfront 2-stenting strategy versus upfront drug-coated balloon (DCB)-based hybrid strategy in patients with complex coronary bifurcation with clinically relevant side branch lesions.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-05; most recent amendment 2025-11-19.
Status change: Not Yet Recruiting → Recruiting 2025-11-19
Trial Details
NCT Number NCT07019350
Lead Sponsor Samsung Medical Center
Conditions Coronary Artery Disease
Enrollment 520 participants
Start Date 2025-10-22
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-24